Articles About NASDAQ:ARIA
February 25, 2014
Merck has terminated a partnership with Ariad, abandoning a once-promising experimental cancer drug that was rejected by the FDA in 2012.
February 15, 2014
Investors looking to generate substantial gains over the coming years may want to take a look at these small-cap biotechnology companies.
February 07, 2014
Investor Sarissa Capital Management LP is seeking at least two board seats at Ariad Pharmaceuticals, its third publicly disclosed investment.
February 03, 2014
These two stocks have have significant potential in their respective niches, and investors should take note.